ATLO vs GILD · P/E 15, rev $45.5M vs P/E 18, rev $7.80B
Ames National Corporation (ATLO) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Ames National Corporation (ATLO) is a banks - regional company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported ATLO revenue for 2026-06-30 was $45.5M. Net income was $11.9M. ATLO currently screens at market cap $165.7M and trailing P/E 14.6.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
ATLO currently screens at market cap $165.7M and trailing P/E 14.6. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the ATLO and GILD stock pages for the full models.
Not investment advice.